Medtronic leaders to speak on artificial intelligence and digital twin technology at upcoming NVIDIA GTC

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that Jim Peichel, chief technology officer, and Rodolphe Katra, chief AI officer, will be speaking live on how artificial intelligence, simulation and digital twins are transforming healthcare at NVIDIA GTC March 16-19 in San Jose, California.

Medtronic executives will join industry leaders to discuss how AI-powered simulation technologies are enabling more predictive, personalized care and helping clinicians plan complex procedures.

Wednesday, March 18 11:00 -11:40 a.m. PDT
Presenter: Jim Peichel

NVIDIA GTC attracts more than 30,000 attendees, including developers, researchers, and business leaders for the latest in AI and accelerated computing. Virtual and in-person registration for GTC is available online.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Justin Paquette
Public Relations
+1-612-271-7935

Ingrid Goldberg
Investor Relations
+1-763-505-2696